Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB

PHASE3CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

May 28, 2019

Study Completion Date

August 28, 2019

Conditions
Peripheral Arterial Diseases
Interventions
DRUG

Actovegin

Actovegin intravenous infusion and tablets.

DRUG

Placebo

Actovegin placebo-matching intravenous infusion and tablets.

Trial Locations (20)

111020

"SBHI of Moscow city City clinical hospital #29 n.a. N.E. Bauman of Moscow Healthcare department", Moscow

111539

SBHI of Moscow healthcare department City clinical hospital #15 n.a. O.M Filatov of Moscow healthcare department, Moscow

129090

SBHI of Moscow Research Institute of Emergency Medicine n.a. N.V. Sklifosofsky of Moscow Healthcare department, Moscow

191015

North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg

194354

SPb SBHI City multipurpose hospital #2, Saint Petersburg

197022

Pavlov First Saint Petersburg State Medical University, Faculty surgery chair, cardio-vessel surgery department, Saint Petersburg

198260

SPb SBHI Consulting and diagnostic center #85, Saint Petersburg

305007

BMH Kursk regional clinical hospital of Healthcare department of Kursk region, Kursk

344022

FSBEI HE Rostov State Medical University of MoH of Russia, Rostov-on-Don

354057

"Municipal State Budgetary Healthcare Institution of Sochi City hospital 4", Sochi

390026

"SBHI of Ryazan region Regional clinical cardiological dispensary, vessel surgery department/ FSBI of Ryazan Region Ryazan State Medical Univesity n.a. I.P. Pavlov of MoH of Russia", Ryazan

410053

"State Healthcare Institution of Saratov region Region clinical hospitai", Saratov

454092

NSHI Road clinical hospital at Chelyabinsk station of OAO RZD, Chelyabinsk

630117

Scientific Research Institute of Clinical and Experimental Lymphology - a branch of the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk

644111

BHI of Omsk region Regional clinical hospital, vessel surgery department, Omsk

650002

Federal state budgetary research institution Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo

0159

Center of Vascular and Heart Disease, Tbilisi

0160

Aversi Clinic, Tbilisi

Z05K4F3

"National scientific centre of oncology and transplantology", Astana

X09E1G4

Regional Clinic Hospital, Shymkent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03469349 - Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB | Biotech Hunter | Biotech Hunter